Investors

Date	Name	Title	Type	Shares Traded	Price Range
Mar 9, 2011	brown michael s	Director	Option Execute	5,000	15.01
Aug 6, 2012	brown michael s	Director	Option Execute	3,000	23.84
Oct 25, 2012	brown michael s	Director	Option Execute	2,000	23.84
Oct 26, 2012	brown michael s	Director	Option Execute	3,000	23.84
Nov 14, 2012	brown michael s	Director	Option Execute	7,000	23.84
Mar 21, 2013	brown michael s	Director	Option Execute	15,000	18.61
Mar 1, 2012	brown michael s	Director	Option Execute	20,000	15.80 - 19.69
Sep 7, 2011	brown michael s	Director	Option Execute	5,000	9.17
Sep 8, 2011	brown michael s	Director	Option Execute	5,000	9.17
Sep 21, 2011	brown michael s	Director	Option Execute	5,000	9.17
May 15, 2013	brown michael s	Director	Option Execute	15,000	24.41
May 6, 2013	gilman alfred g	Director	Option Execute	30,000	19.69 - 23.84
Feb 14, 2012	gilman alfred g	Director	Option Execute	30,000	9.17 - 15.01
Aug 7, 2012	gilman alfred g	Director	Option Execute	15,000	15.80
Mar 17, 2011	gilman alfred g	Director	Option Execute	30,000	18.80 - 28.81
May 27, 2010	gilman alfred g	Director	Option Execute	5,000	25.43
Jan 21, 2009	gilman alfred g	Director	Option Execute	10,000	7.66
Feb 20, 2008	gilman alfred g	Director	Option Execute	10,000	7.91
Jan 2, 2009	goldberg murray a	Officer	Option Execute	1,300	7.41
Dec 15, 2008	goldberg murray a	Officer	Option Execute	1,700	7.41
Showing 401-420 of 639 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.